Ozempic Alert: New Trial Causes DaVita (DVA) Stock to Plunge 20%
InvestorPlaceInvestorPlace – Stock Market News, Stock Advice & Trading Tips
Ozempic may be able to treat kidney disease. This news has sent competitor DaVita into a tailspin as DVA stock plunges.
The post Ozempic Alert: New Trial Causes DaVita (DVA) Stock to Pl…